comparemela.com

Fenix Advisory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hansa Biopharma AB recognizes a write-up of SEK 1 430 billion in intangible assets related to Idefirix in the financial

LUND, Sweden, July 4, 2023 /PRNewswire/ Hansa Biopharma AB (publ.) (Nasdaq Stockholm: HNSA), a pioneer in.

United kingdomPrnewswire hansa biopharmaStephanie kenneyKlaus sindahlEuropean unionKhansa groupNasdaq stockholmSwedish annual accounts actHansa biopharmaFenix advisoryAbuse regulationInvestor relationsmCorporate affairsm

Hansa Biopharma AB recognizes a write-up of SEK 1 430 billion in intangible assets related to Idefirix in the financial statements of the parent company

/PRNewswire/ Hansa Biopharma AB (publ.) (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announces today that, in.

United kingdomKlaus sindahlPrnewswire hansa biopharmaStephanie kenneyEuropean unionKhansa groupVp global corporate affairsNasdaq stockholmSwedish annual accounts actHansa biopharmaFenix advisoryAbuse regulation

vimarsana © 2020. All Rights Reserved.